Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03902912 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Prednisolone Treatment on Uterine Natural Killer Cells

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. 2 versions Re-verified since Nov 30, 2023, no change to tracked fieldsv6-v7
  2. Primary completion date: Apr 30, 2022 to Apr 30, 2027 Completion date: Apr 30, 2023 to Apr 30, 2028 · Site contact updatedv5 Show 2 more changesShow less
    • Completion date: Apr 30, 2023 to Apr 30, 2028
    • Site contact updated
  3. Site contact updatedv4
  4. Re-verified, no change to tracked fieldsv3
  5. Trial status: Not Yet Recruiting to Recruiting Start date: May 1, 2019 to Jul 30, 2019 · Study sites: 0 to 1v2 Show 2 more changesShow less
    • Start date: May 1, 2019 to Jul 30, 2019
    • Study sites: 0 to 1
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to investigate the role of uNK cells and the association with prednisolone.
Trial Details
NCT Number NCT03902912
Lead Sponsor Chinese University of Hong Kong
Conditions Recurrent Miscarriage
Enrollment 84 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov